Skip to main content

Cytisinicline Beneficial for Cessation of Electronic Cigarette Smoking

Medically reviewed by Carmen Pope, BPharm. Last updated on May 13, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, May 13, 2024 -- Cytisinicline for 12 weeks with behavioral support is efficacious for cessation of electronic cigarette smoking, according to a study published online May 6 in JAMA Internal Medicine.

Nancy A. Rigotti, M.D., from Massachusetts General Hospital in Boston, and colleagues examined the efficacy and safety of cytisinicline versus placebo for abstinence from e-cigarette use in a double-blind, randomized clinical trial. One hundred sixty adults who vaped nicotine daily, sought to quit, and did not currently smoke cigarettes were enrolled; 81.9 percent completed the trial. Participants were randomly assigned to cytisinicline 3 mg, three times daily, or placebo for 12 weeks (107 and 53 participants, respectively). All participants also received weekly behavioral support.

The researchers found that continuous e-cigarette abstinence occurred in 31.8 versus 15.1 percent of participants in the cytisinicline and placebo groups, respectively, at the end of treatment (weeks 9 to 12; odds ratio, 2.64; 95 percent confidence interval, 1.06 to 7.10; P = 0.04). During weeks 9 to 16, continuous e-cigarette abstinence occurred in 23.4 and 13.2 percent, respectively (odds ratio, 2.00; 95 percent confidence interval, 0.82 to 5.32; P = 0.15). Based on nonsignificant interactions, there was no evidence that cytisinicline efficacy differed in subgroups defined by demographic characteristics, vaping pattern, e-cigarette dependence, or smoking history. Cytisinicline was well tolerated; only 3.8 percent of participants discontinued treatment due to an adverse event.

"For individuals seeking to quit vaping, cytisinicline might fill the existing gap in pharmacologic treatments and enhance the emerging evidence of efficacy of behavioral treatments for vaping cessation," the authors write.

Several authors disclosed ties to industry, including law firms in litigation against tobacco companies.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

E-Cigarette Use After Smoking May Up Risk for Lung Cancer

WEDNESDAY, May 22, 2024 -- Former cigarette smokers who use electronic cigarettes may have a higher risk for lung cancer than those who do not vape, according to a study presented...

Use of Electronic Cigarettes Tied to Earlier Age at Onset of Adult Asthma

FRIDAY, May 17, 2024 -- Past 30-day electronic nicotine delivery systems (ENDS) use among adults is associated with earlier ages of asthma onset, according to a study published...

Greater Teen Social Media Use Tied to Increased Cigarette Use

FRIDAY, May 17, 2024 -- Social media use is associated with an increased risk for cigarette smoking and electronic cigarette use in teens and young adults, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.